Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Sclerosis Lesion”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Not applicableLooking for participantsNCT05123443
What this trial is testing

Longitudinal Assessment of Iron Rims in MS Lesions

Who this might be right for
Multiple Sclerosis
Nottingham University Hospitals NHS Trust 100
Large-scale testing (Phase 3)Study completedNCT00799890
What this trial is testing

Sunphenon in Progressive Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Friedemann Paul 61
Large-scale testing (Phase 3)Study completedNCT03315923
What this trial is testing

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Secondary Progressive Multiple Sclerosis Patients

Who this might be right for
Secondary Progressive Multiple Sclerosis
Isfahan University of Medical Sciences 84
Not applicableLooking for participantsNCT04906928
What this trial is testing

Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

Who this might be right for
Spinal Cord Injuries
Fondation Ophtalmologique Adolphe de Rothschild 200
Not applicableActive Not RecruitingNCT07705581
What this trial is testing

Validation and Standardization of Paramagnetic Rim Lesion (PRL) Identification in Multiple Sclerosis Across MAGNIMS Centers

Who this might be right for
Multiple Sclerosis
IRCCS San Raffaele 1,402
Not applicableStudy completedNCT05426980
What this trial is testing

Artificial Intelligence in Predicting Progression in Multiple Sclerosis Study

Who this might be right for
Multiple SclerosisMultiple Sclerosis LesionMultiple Sclerosis Brain Lesion
University of Ljubljana 654
Not applicableEnded earlyNCT03660618
What this trial is testing

LSFG-SKIN, Laser Speckle Flowgraphy

Who this might be right for
HypertensionHeart FailureVascular Ischemia+13 more
Randy Kardon 1
Not applicableLooking for participantsNCT05776511
What this trial is testing

Diagnostic Value of eVOG

Who this might be right for
Multiple SclerosisRadiologically Isolated SyndromeWhite Matter Lesions
Centre Hospitalier Universitaire de Nice 150
Testing effectiveness (Phase 2)Ended earlyNCT02466074
What this trial is testing

Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
The University of Texas Health Science Center, Houston 5
Large-scale testing (Phase 3)Active Not RecruitingNCT05147220
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,000
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Not applicableStudy completedNCT00861172
What this trial is testing

Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy

Who this might be right for
LesionsMultiple Sclerosis
Hospices Civils de Lyon 6
Not applicableLooking for participantsNCT05482906
What this trial is testing

Common and Specific Information From Neuroimaging and Smartphone

Who this might be right for
Multiple Sclerosis
Nantes University Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT06220669
What this trial is testing

LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Eli Lilly and Company 63
Not applicableStudy completedNCT03401307
What this trial is testing

Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurodegenerationCentral Nervous System Lesion+5 more
University of Southern Denmark 49
Not applicableStudy completedNCT03268239
What this trial is testing

Contrast-enhanced 3D T1-weighted Gradient-echo Versus Spin-echo 3 Tesla MR Sequences in the Detection of Active Multiple Sclerosis Lesions

Who this might be right for
Magnetic Resonance ImagingCentral Nervous SystemBrain+2 more
Fondation Ophtalmologique Adolphe de Rothschild 180
Large-scale testing (Phase 3)Active Not RecruitingNCT05156281
What this trial is testing

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 1,007
Not applicableStudy completedNCT07687693
What this trial is testing

Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Region Stockholm 11
Not applicableLooking for participantsNCT05227092
What this trial is testing

3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

Who this might be right for
Multiple Sclerosis
University Hospital, Bordeaux 60
Next Page